Across TCGA pan-cancer cohorts, CPOX RNA is linked to patient survival in 28 of 34 cancer types, making it the most broadly survival-associated CPOX data layer compared with 4 for mutation status and 7 for mass-spec protein.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CPOX RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CPOX expression acts as an unfavorable survival marker, although some lineages such as READ and LUSC show a favorable association.
KIRP, LGG, and THCA are the cancer types where CPOX RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.